Vanda Pharmaceuticals, Inc. (VNDA)
7.93
+0.22
(+2.85%)
USD |
NASDAQ |
Jan 21, 16:00
7.94
+0.01
(+0.13%)
After-Hours: 07:32
Vanda Pharmaceuticals Free Cash Flow: -82.95M for Sept. 30, 2025
Free Cash Flow Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Free Cash Flow Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Free Cash Flow Benchmarks
| Aldeyra Therapeutics, Inc. | -40.08M |
| Eli Lilly & Co. | 6.436B |
| ADMA Biologics, Inc. | 40.61M |
| Axsome Therapeutics, Inc. | -101.39M |
| AnaptysBio, Inc. | -145.42M |
Free Cash Flow Related Metrics
| Cash from Operations (Quarterly) | -31.63M |
| Cash from Investing (Quarterly) | 21.36M |
| Cash from Financing (Quarterly) | -0.517M |
| Free Cash Flow Per Share (Quarterly) | -0.5379 |
| Free Cash Flow to Equity (Quarterly) | -31.06M |
| Free Cash Flow to Firm (Quarterly) | -31.79M |
| Free Cash Flow Yield | -17.81% |